StockData

Bio Key International vs T Stamp

BKYI and IDAI side by side, both in computer programming, data processing, and other computer related services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How BKYI and IDAI compare

T Stamp is the larger company, worth 4.6 times as much as Bio Key International ($12.7M against $2.8M).

T Stamp grew revenue faster over the last twelve months (2.1% versus −3.1% for Bio Key International).

Bio Key International keeps more of each dollar of sales as profit, with a net margin of −90.1% compared with −441% at T Stamp.

Bio Key International scores higher on the StockData Score (6 against 3 for T Stamp), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricBKYIIDAI
Size and price
Market cap$2.8M$12.7M
Share price$1.94$2.26
Change, 1 year−79.6%−51.5%
Change, 5 years−99.6%−91.4%
Beta (5Y)−0.902.83
Employees429
StockData Score
Total score6 (better)3
Valuation score3 (better)1
Growth score1 (better)0
Performance score1 (better)0
Health score12 (better)
Dividend score00
Valuation
P/S0.4× (better)3.7×
P/B0.6× (better)2.7×
FCF yield−149%−77.0% (better)
Fair value$7.06$1.34
Margin of safety72.5% (better)−68.1%
Growth
Revenue growth (TTM)−3.1%2.1% (better)
Revenue growth, 5Y average15.9%28.3% (better)
Profitability
Gross margin81.3%–
Operating margin−86.4% (better)−247%
Net margin−90.1% (better)−441%
FCF margin−62.1% (better)−285%
Return on equity−108% (better)−428%
Return on invested capital−121% (better)−496%
Financial health
Debt / equity–0.24
Interest coverage−108.4×–
Current ratio1.266.48 (better)
Altman Z-score−26.68−8.69 (better)
Piotroski F-score34 (better)
Dividends and buybacks
Buyback yield–−78.7%
Shareholder yield0.00% (better)−78.7%
Ownership
Held by institutions0.00%5.5%
Held by insiders83.3%32.5%
Insider net buying, 12 months–$65.3K
Short interest, % of float113%2.5%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.